News tagged ‘ColonCancer’ clear
- Newly discovered gene mutations in certain non-small cell and colorectal cancers share similarities with other genetic abnormalities that are known to respond to targeted cancer treatments. This suggests that existing therapies, already approved, could be used to treat patients with these tumors.
Tags: ColonCancer, Genomics, KinaseInhibitor, LungCancer, TargetedTherapy
- The vast majority of advanced colon cancer patients in a clinical trial
were not concerned about the cost of prescription drugs, according to a
study led by Dana-Farber researchers.
Tags: chemotherapy, ColonCancer
- Dana-Farber Cancer Institute researchers report that when people with a family history of colorectal cancer develop the disease, their tumors often carry a molecular sign that the cancer could be life-threatening.
- Research explores why people with surgically removed colorectal cancer
who are overweight, physically inactive, and follow a Western-pattern
diet may have increased risk of dying from the disease or other causes.
- An observational study is among the first to show that aspirin can
improve survival in colorectal cancer patients who started taking
aspirin following diagnosis.
- Dana-Farber and the Broad Institute researchers have found high levels of the bacterium Fusobacterium in colorectal cancers, a sign that it might contribute to the disease and potentially lead to further research.
Tags: BasicResearch, ColonCancer, Genomics
- Dana-Farber scientists show a previously unsuspected gene can
also influence transcription factors and potentially disable tumor
Tags: ColonCancer, Genetics
- People with advanced colon cancer who have smoked cigarettes or
used other tobacco products for many years may have an increased risk
that their colon cancer will return, according to research by
Dana-Farber Cancer Institute scientists.
Tags: ColonCancer, Smoking
- Patients diagnosed with colon cancer who had abundant vitamin D
in their blood were less likely to die during a follow-up period than
those who were deficient in the vitamin, according to a new study by
scientists at Dana-Farber Cancer Institute.
- Dana-Farber researchers have discovered how some cancer cells can evade the effect of cetuximab. This insight may explain why some cancers that initially respond to cetuximab become resistant to it, or how to overcome such resistance.
Tags: ColonCancer, EGFR, TargetedTherapy
Showing 11-20 of 24 items